-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Downgrades Globus Medical to Market Perform, Lowers Price Target to $78

Benzinga·11/06/2026 11:02:59
Listen to the news
BMO Capital analyst Vik Chopra downgrades Globus Medical (NYSE:GMED) from Outperform to Market Perform and lowers the price target from $94 to $78.